Discontinuation of Levothyroxine Therapy for Patients With Subclinical Hypothyroidism

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 24, 2021

Primary Completion Date

October 7, 2022

Study Completion Date

December 31, 2022

Conditions

Subclinical Hypothyroidism

Interventions

DRUG

Levothyroxine

Participants will be instructed to start the study medication the day after randomization. The study medication will be taken orally once a day.

OTHER

Placebo

Participants will be instructed to start the study medication the day after randomization. The study medication will be taken orally once a day.

Trial Locations (1)

Central Arkansas Veterans Healthcare System Eugene J. Towbin Healthcare Center, Little Rock, AR, North Little Rock

All Listed Sponsors

collaborator

Central Arkansas Veterans Healthcare System

FED

lead

VA Office of Research and Development

FED

NCT04288115 - Discontinuation of Levothyroxine Therapy for Patients With Subclinical Hypothyroidism | Biotech Hunter | Biotech Hunter